Status:
UNKNOWN
Early Recovery After Cesarean Delivery - Maternal Glucose Homeostasis Following Preoperative Glucose Dose
Lead Sponsor:
Women's Hospital HUS
Conditions:
Gestational Diabetes
Cesarean Section Complications
Eligibility:
FEMALE
18-55 years
Brief Summary
Diabetic parturients planned for cesarean delivery will be recruited for the study. They will receive a fixed glucose dose to mimize the effects of fasting preoperatively and their blood glucose level...
Detailed Description
Informed voluntary parturients planned for cesarean delivery will be informed about the study. The parturients will get prepacked glucose drink containing 100 g and 50 g glucose, respectively. They wi...
Eligibility Criteria
Inclusion
- Volunteers to participate in the study
- Diabetes, either gestational or type II
- Planned for cesarean delivery
Exclusion
- Type I diabetes
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05396378
Start Date
July 1 2023
End Date
December 31 2023
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HUS/Women's hospital dept of obstetrics
Helsinki, Finland, 00029